Progress in Pediatric Cardiology
Volume 28, Issue 1 , Pages 11-19 , January 2010

The role of late gadolinium enhancement cardiovascular magnetic resonance in the assessment of congenital and acquired heart disease

  • Sonya V. Babu-Narayan

      Affiliations

    • Corresponding Author InformationAdult Congenital Heart Unit, Royal Brompton Hospital, Sydney Street, London SW3 6NP, United Kingdom. Tel.: +44 20 7351 8602; fax: +44 20 7351 8629.

References 

  1. Judd RM, Lugo-Olivieri CH, Arai M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation. Oct 1 1995;92(7):1902–1910
  2. Kim RJ, Chen EL, Lima JA, et al. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation. Dec 15 1996;94(12):3318–3326
  3. Wu E, Judd RM, Vargas JD, et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. Jan 6 2001;357(9249):21–28
  4. Choudhury L, Mahrholdt H, Wagner A, et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. Dec 18 2002;40(12):2156–2164
  5. Moon JC, McKenna WJ, McCrohon JA, et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. May 7 2003;41(9):1561–1567
  6. McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. Jul 8 2003;108(1):54–59
  7. Smedema JP, Winckels SK, Snoep G, et al. Tropical endomyocardial fibrosis (Davies' disease): case report demonstrating the role of magnetic resonance imaging. Int J Cardiovasc Imaging. Dec 2004;20(6):517–522
  8. Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. Jan 18 2005;111(2):186–193
  9. Ibrahim T, Bulow HP, Hackl T, et al. Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. J Am Coll Cardiol. Jan 16 2007;49(2):208–216
  10. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. Jan 2001;218(1):215–223
  11. Kim RJ, Shah DJ, Judd RM. How we perform delayed enhancement imaging. J Cardiovasc Magn Reson. Jul 2003;5(3):505–514
  12. Desai MY, Stone JH, Foo TK, et al. Delayed contrast-enhanced MRI of the aortic wall in Takayasu's arteritis: initial experience. AJR Am J Roentgenol. May 2005;184(5):1427–1431
  13. Grosse-Wortmann L, Al-Otay A, Goo HW, et al. Anatomical and functional evaluation of pulmonary veins in children by magnetic resonance imaging. J Am Coll Cardiol. Mar 6 2007;49(9):993–1002
  14. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. Nov 16 2000;343(20):1445–1453
  15. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. Feb 1 2003;361(9355):374–379
  16. Taylor AM, Dymarkowski S, Hamaekers P, et al. MR coronary angiography and late-enhancement myocardial MR in children who underwent arterial switch surgery for transposition of great arteries. Radiology. Feb 2005;234(2):542–547
  17. Puranik R, Greaves K, Hawker RE, et al. Abnormal right ventricular tissue velocities after repair of congenital heart disease—implications for late outcomes. Heart Lung Circ. Aug 2007;16(4):295–299
  18. Moon JC, Fisher NG, McKenna WJ, et al. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart. Jun 2004;90(6):645–649
  19. Petersen SE, Jerosch-Herold M, Hudsmith LE, et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation. May 8 2007;115(18):2418–2425
  20. Kwon DH, Smedira NG, Rodriguez ER, et al. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol. Jul 14 2009;54(3):242–249
  21. Moon JC, Reed E, Sheppard MN, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. Jun 16 2004;43(12):2260–2264
  22. Papavassiliu T, Schnabel P, Schroder M, et al. CMR scarring in a patient with hypertrophic cardiomyopathy correlates well with histological findings of fibrosis. Eur Heart J. Nov 2005;26(22):2395
  23. Adabag AS, Maron BJ, Appelbaum E, et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol. Apr 8 2008;51(14):1369–1374
  24. Maron BJ, Spirito P, Shen WK, et al. Implantable cardioverter–defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. Jul 25 2007;298(4):405–412
  25. Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. Nov 21 2006;48(10):1977–1985
  26. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. Mar 16 2004;109(10):1250–1258
  27. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol. Apr 28 2009;53(17):1475–1487
  28. Friedrich MG, Strohm O, Schulz-Menger J, et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation. May 12 1998;97(18):1802–1809
  29. Vogelsberg H, Mahrholdt H, Deluigi CC, et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol. Mar 11 2008;51(10):1022–1030
  30. Tandri H, Saranathan M, Rodriguez ER, et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol. Jan 4 2005;45(1):98–103
  31. Norman M, Simpson M, Mogensen J, et al. Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation. Aug 2 2005;112(5):636–642
  32. Babu-Narayan SV, Goktekin O, Moon JC, et al. Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries. Circulation. Apr 26 2005;111(16):2091–2098
  33. Giardini A, Lovato L, Donti A, et al. Relation between right ventricular structural alterations and markers of adverse clinical outcome in adults with systemic right ventricle and either congenital complete (after Senning operation) or congenitally corrected transposition of the great arteries. Am J Cardiol. Nov 1 2006;98(9):1277–1282
  34. McCann GP, Beek AM, Vonk-Noordegraaf A, et al. Delayed contrast-enhanced magnetic resonance imaging in pulmonary arterial hypertension. Circulation. Oct 18 2005;112(16):e268
  35. Mark PB, Johnston N, Groenning BA, et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int. May 2006;69(10):1839–1845
  36. Babu-Narayan SV, Kilner PJ, Li W, et al. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation. Jan 24 2006;113(3):405–413
  37. Wald RM, Haber I, Wald R, et al. Effects of regional dysfunction and late gadolinium enhancement on global right ventricular function and exercise capacity in patients with repaired tetralogy of Fallot. Circulation. Mar 17 2009;119(10):1370–1377
  38. Oosterhof T, Mulder BJ, Vliegen HW, et al. Corrected tetralogy of Fallot: delayed enhancement in right ventricular outflow tract. Radiology. Dec 2005;237(3):868–871
  39. Rathod Rahul HPA, Powell Andrew J, Geva Tal. Location, patterns, and quantification of myocardial fibrosis identified by cardiac magnetic resonance delayed enhancement late after Fontan operation. J Cardiovasc Magn Reson. January 28th 2009;11(Supplement 1):41
  40. Taylor AM, Dymarkowski S, Verbeken EK, et al. Detection of pericardial inflammation with late-enhancement cardiac magnetic resonance imaging: initial results. Eur Radiol. Mar 2006;16(3):569–574
  41. Flett Andrew SWMA, Davies Ceri, Mathur Anthony, Moon James C. The prognostic implications of cardiovascular magnetic resonance. Circ Cardiovasc Imag. May 2009;2:243–250
  42. Wellnhofer E, Olariu A, Klein C, et al. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation. May 11 2004;109(18):2172–2174
  43. Bello D, Shah DJ, Farah GM, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation. Oct 21 2003;108(16):1945–1953
  44. White JA, Yee R, Yuan X, et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol. Nov 21 2006;48(10):1953–1960
  45. Bleeker GB, Kaandorp TA, Lamb HJ, et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation. Feb 21 2006;113(7):969–976
  46. Chalil S, Stegemann B, Muhyaldeen SA, et al. Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy. Pacing Clin Electrophysiol. Oct 2007;30(10):1201–1209
  47. Uebing A, Gibson DG, Babu-Narayan SV, et al. Right ventricular mechanics and QRS duration in patients with repaired tetralogy of Fallot: implications of infundibular disease. Circulation. Oct 2 2007;116(14):1532–1539
  48. Barnes RJ, Kwong KH, Cheung AC. Aberrant muscle bundle of the right ventricle. Br Heart J. Jul 1971;33(4):546–551
  49. Bello D, Fieno DS, Kim RJ, et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol. Apr 5 2005;45(7):1104–1108
  50. Hombach V, Grebe O, Merkle N, et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J. Mar 2005;26(6):549–557
  51. Yan AT, Shayne AJ, Brown KA, et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation. Jul 4 2006;114(1):32–39
  52. Nazarian S, Bluemke DA, Lardo AC, et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation. Nov 1 2005;112(18):2821–2825
  53. Bogun FM, Desjardins B, Good E, et al. Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate. J Am Coll Cardiol. Mar 31 2009;53(13):1138–1145
  54. McGann CJ, Kholmovski EG, Oakes RS, et al. New magnetic resonance imaging-based method for defining the extent of left atrial wall injury after the ablation of atrial fibrillation. J Am Coll Cardiol. Oct 7 2008;52(15):1263–1271

PII: S1058-9813(09)00038-1

doi: 10.1016/j.ppedcard.2009.10.006

Progress in Pediatric Cardiology
Volume 28, Issue 1 , Pages 11-19 , January 2010

Article Tools

* Image Usage & Resolution